Cita APA

Gwak, H., Park, H., Lin, W., Shin, S., Yoo, H., Kwon, J., . . . Yoo, B. (2017). OS03.2 CSF metabolomic profiles can discriminate patients with leptomeningeal carcinomatosis from patients having high risk for leptomeningeal metastasis from brain metastasis or brain tumors. Neuro Oncol.

Chicago Style Citation

Gwak, H., H. Park, W. Lin, S. Shin, H. Yoo, J. Kwon, J. Lee, K. Kim, i B. Yoo. "OS03.2 CSF Metabolomic Profiles Can Discriminate Patients With Leptomeningeal Carcinomatosis From Patients Having High Risk for Leptomeningeal Metastasis From Brain Metastasis or Brain Tumors." Neuro Oncol 2017.

Cita MLA

Gwak, H., et al. "OS03.2 CSF Metabolomic Profiles Can Discriminate Patients With Leptomeningeal Carcinomatosis From Patients Having High Risk for Leptomeningeal Metastasis From Brain Metastasis or Brain Tumors." Neuro Oncol 2017.